Knowledge-Based CPE Learning Activity on Antimicrobial Stewardship

  • Wednesday, April 20, 2016
  • 4:15 PM
  • The Crowne Plaza at the Crossings

Registration


Registration is closed


Knowledge-Based CPE Learning Activity on Antimicrobial Stewardship 

Pharmacists and Pharmacy Technicians

2.0 Contact Hours (0.2 CEUs)


Wednesday, April 20, 2016

 The Crowne Plaza at the Crossings

801 Greenwich Avenue, Warwick, RI 02886

401-732-6000

 

Part 1: Current Practices in Clinical Microbiology: A Review of Conventional and Molecular Clinical Microbiology with a Focus on Stewardship Opportunities

Tristan T. Timbrook, PharmD, MBA, BCPS

Post-Doctoral Outcomes in Antimicrobial Stewardship Fellow

VAMC Providence

Part 2: GAINing Ground with Newly Approved Antimicrobials

Jacob Morton, PharmD, MBA, BCPS

Post-Doctoral Outcomes in Antimicrobial Stewardship Fellow

VAMC Providence

   

Program Agenda: 

              4:15 PM              Registration 

              5:00 PM              Buffet Dinner Starts

              5:15-6:15 PM      Part 1

              6:15-6:30 PM      Break

              6:30-7:30 PM      Part 2

   

Members               $25.00

Non-Members       $50.00

Please register on-line only. Please do not mail in registrations. Fees are payable at sign-in or online via Paypal Online: www.rishp.org.  Refund requests must be made by written request and are at the discretion of the RISHP Board of Directors.

 

Learning Objectives:

Upon completion of this learning activity, pharmacist participants will be able to:

  • Discuss conventional microbiologic methods for common specimens for gram positive and negative organisms.
  • Explain how new molecular clinical microbiology methods fit into current practice.
  • State what antimicrobial stewardship interventions can be achieved with both conventional and molecular diagnostic methods.
  • Describe mandates from the Generating Antibiotics Incentives Now (GAIN) Act.
  • Discuss the characteristics of recently approved antimicrobials.
  • Review clinical trial data supporting the place in therapy for new antimicrobials.
Upon completion of this learning activity, pharmacy technician participants will be able to:
  • Recognize adverse drug reactions to common empiric therapies that rapid diagnostics can help to reduce by limiting unneeded drug exposures.
  • Explain the importance of time to appropriate antibiotic therapy and how pharmacy distribution of antibiotics play an important role in patient outcomes.
  • List ways that pharmacy can perform inventory management to ensure antibiotics are on hand that meet the needs of patients based on local bacteria resistance patterns.
  • Describe mandates from the Generating Antibiotics Incentives Now (GAIN) Act.
  • Review brand and generic names of recently approved antimicrobials.
  • Discuss pharmacologic characteristics of new antimicrobials.






For website issues issues, please click here

Powered by Wild Apricot Membership Software